Advancing Global Health Equity & HarmonizationVIEW EVENT DETAILS
Inaugural Cure4Cancer Conference & 6th Annual MSK-CTONG Annual Symposium
Cancer continues to devastate the lives of patients, their families and loved ones, causing 10 million deaths worldwide every year. Clinical trials represent the critical step in translating scientific discoveries into life-saving treatments and prevention. However, despite an industry investment of more than $80 billion annually in global oncology research and development (R&D), less than 5% of patients currently have access to clinical trials and the typical R&D timeline is 10-15 years. This situation needs to be urgently changed.
Memorial Sloan Kettering Cancer Center (MSK), Chinese Thoracic Oncology Group (CTONG), and Asia Society Policy Institute (ASPI) recognize the urgent need for a multi-stakeholder approach to break down barriers and accelerate the development and access to life-saving treatments globally. Cure4Cancer was initiated in response. Cure4Cancer is an international movement that emerged to accelerate the development of cancer cures and prevention through increased public awareness, cooperation, and regulatory harmonization on patient-centric international clinical trials and at the same time promoting industry innovation and global peace in the fight against cancer — our common enemy — for the betterment of all humanity.
Join us for the first annual Cure4Cancer conference focused on advancing global health equity and harmonization. Leveraging enormous collaborative synergy, the inaugural conference will be combined with the 6th annual MSK-CTONG Symposium to foster academic collaboration, and cooperation with industry and government stakeholders to advance our mission for the eradication of cancer as a major cause of death in this lifetime. This exciting conference will feature keynotes and panel discussions from high-level industry and government stakeholders.
|8:30 – 9:00 a.m.|
Registration and Light Breakfast
|9:00 - 9:10 a.m.|
|9:10 - 9:45 a.m.|
|09:50 - 10:35 a.m.|
International Regulatory Harmonization and Collaboration for Accelerating Cancer Cures
|10:35 - 10:45 a.m.|
Coffee and tea break
|10:45 - 11:00 a.m.|
|11:00 a.m. - 11:45 p.m.|
Promoting Patient-Centric Cancer Clinical Trials
|11:50 - 12:35 p.m.|
Expanding Global Health Equity in Clinical Trial Access and Participation
|End of Public Program|
This conference is presented in partnership with Memorial Sloan Kettering Cancer Center, the Chinese Thoracic Oncology Group, and our Cure4Cancer partners.
Tolulope Adewole, MD, Managing Director, NSIA Advanced Medical Services Limited (Medserve), Nigeria
Shelly Anderson, MPM, Hospital President, Memorial Sloan Kettering
Otis Brawley, MD, Associate Director, Community Outreach and Engagement Sidney Kimmel Comprehensive Cancer Center; Professor of Oncology, Johns Hopkins University School of Medicine, 39th Bloomberg Distinguished Professor, Bloomberg School of Public Health, Johns Hopkins.
Stephen Clarke, MD, PhD, Senior Staff Specialist Medical Oncologist, Royal North Shore Hospital; Professor of Medicine, University of Sydney, Australia
Terri Conneran, Founder and Director, KRAS Kickers
Jennifer Dent, President and CEO, BIO Ventures for Global Health (BVGH)
Lisa D’Angelis, MD, Chief Physician Executive; Scott M. And Lisa G. Stuart Chair, Memorial Sloan Kettering Cancer Center
Luis Diaz Jr., MD, Head, Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center; President Biden's Appointed Member, National Cancer Advisory Board
Debra Eisenman, Chief Operating Officer and Executive Vice President, Asia Society; Founding Director and Senior Fellow, Asia Society Policy Institute
David Fredrickson, Executive Vice-President, Oncology Business, AstraZeneca
Adedayo Joseph, MD, Research Program Director, NSIA-LUTH Cancer Center, Nigeria
Lillian Leigh, Membership and Advocacy Chair, Board Member, Thoracic Oncology Group Australasia (TOGA)
Bob Li, MD, Physician Ambassador to China and Asia-Pacific, Memorial Sloan Kettering Cancer Center; Associate Professor of Medicine, Weill Cornell Medicine, Cornell University; Senior Fellow on Global Public Health, Center for China Analysis, Asia Society Policy Institute
Isabel Mestres, CEO, City Cancer Challenge Foundation (C/Can)
Sebastian Mondaca, MD, Director of the Cancer Institute at Red de Salud UC-Christus; Assistant Professor, Pontificia Universidad Católica, Chile
Paulo Nigro, CEO, Hospital Sirio-Libanes, Brazil
John V. Oyler, Co-Founder, CEO, and Chairman of BeiGene
Simon Powell, MD, PhD, FRCP, Chairman, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center
Jing Qian, Co-Founder and Managing Director, Center for China Analysis, Asia Society Policy Institute; Advisory Board Member, Bloomberg New Economy
The Hon Dr. Kevin Rudd AC, Australian Ambassador to the United States; Former President and CEO, Asia Society; 26th Prime Minister of Australia
Orville Schell, Author Ross Director of the Asia Society Center for U.S.-China Relations
Deb Schrag, MD, MPH, Chair, Department of Medicine, Memorial Sloan Kettering Cancer Center
Greg Simon, Distinguished Fellow, Global Public Health, Center for China Analysis, Asia Society Policy Institute; Former President, Biden Cancer Initiative
Victoria Wolodzko Smart, Senior Vice President of Mission for Susan G. Komen
Aminu Umar-Sadiq, CEO of Nigerian Sovereign Investment Authority
Helen Wheeler, MD, Head, Department of Medical Oncology, Royal North Shore Hospital; Associate Professor of Medicine, University of Sydney, Australia
Yi-Long Wu, MD, President, Expert Committee Chair, Chinese Thoracic Oncology Group; Chief Expert, Former Vice President of Guangdong Provincial People’s Hospital; Honorary Director of Guangdong Lung Cancer Institute, Director of Guangdong Provincial Key Laboratory of Translational Medicine for Lung Cancer.
Catharine Young, PhD, Assistant Director of Cancer Moonshot Engagement and Policy, White House
Qing Zhou, MD, PhD, President of Cancer Hospital of Guangdong Provincial People’s Hospital & Guangdong Academy of Medical Sciences; Vice-director of Guangdong Lung Cancer Institute (GLCI); Vice-chairman and secretary-general of Chinese Thoracic Oncology Group (CTONG).